Jump to content
  • Welcome to Celiac.com!

    You have found your celiac tribe! Join us and ask questions in our forum, share your story, and connect with others.


  • Celiac.com Sponsor (A1):
    Celiac.com Sponsor (A1-M):
  • Join Our eNewsletter:
    Support Our Content
    eNewsletter
    Donate

Fda Releases Study On Cross-contamination


jenvan

Recommended Posts

jenvan Collaborator

Here is link to full document, or summary below. (This was in Clan Thompson newsletter)

Open Original Shared Link (Makes me think twice...)

The FDA's report to Congress regarding cross-contact with food allergens during

food manufacturing and distribution, and consumer preferences about advisory

labeling is out. This report was required as part of the Food Allergen Labeling

and Consumer Protection Act (FALCPA) and states that foods may become

unintentionally contaminated with major food allergens at almost any step of

manufacturing prior to final packaging. For instance, contamination can occur as

a result of allergens in raw ingredients or in processing aids, or as a result

of allergen carry-over from the use of shared equipment and from clean-in-place

fluid used to clean shared equipment. Dedicated facilities or production lines

can help control cross contamination, but their use is limited due to cost,

space limitations or equipment utilization needs.

It is difficult to determine the prevalence of cross-contamination for several

reasons, according to the FDA. Many instances of cross contamination are not

observable. For example, a raw ingredient can contain an undeclared allergenic

ingredient or processing aid. If the manufacturer doesn't know about the

presence of allergens in raw materials, they can produce food products that are

contaminated.

There is no known processing technology that can be used to automatically or

continuously exclude major allergens from all foods at risk of contamination.

However, good manufacturing practices help reduce or eliminate unintentional

cross contamination. A report prepared for the Center for Food Safety and

Applied Nutrition (CFSAN) by the Institute of Food Technologists (IFT) states

the following: "Most food companies include allergen control as part of their

prerequisite program; most of the food companies have Sanitation Standard

Operating Procedures to delineate their cleaning practices in their allergen

control plan; the majority of the targeted food companies have validated the

effectiveness of their allergen cleaning approaches;" and "the majority of

included food companies train employees on an annual basis on topics related to

allergens."

Between FY2002-FY2004, the FDA conducted over 2,000 allergen-focused

inspections. Investigators determined that allergen cross-contact was likely to

occur in 25% of all inspected facilities during processing of food products.

Sources of contamination included residues of allergen-containing product on

equipment, build-up of product above the processing zone, and presence of

airborne food particles. Overall, equipment residues were judged to be the most

likely source of cross contamination, followed by airborne food particles, and

build-up of product above the processing zone.

Investigators also determined that 76% of all facilities handled unpackaged,

exposed product in a way to protect it against cross contamination with an

allergen.

Inspections done in FY2003-2004 found similar results with respect to receiving,

equipment, processing, testing, and labeling. However, for FY2003-2004, 79% of

the inspected facilities used one or more control measures associated with

production equipment to prevent allergen cross-contact compared to just 8% of

the FY2002 facilities. In the FY2003-2004 inspections, of the facilities that

tried to control cross contamination from equipment, 33% used dedicated

equipment, 74% used shared equipment with clean up in between manufacture of the

allergen containing product and the non-allergen containing product, 41% used

shared equipment with production scheduled to run allergenic product last, and

8.5% used other methods.

For facilities inspected in FY2003-2004, FDA investigators judged that 24% were

likely to have cross contact during processing compared to 25% in FY2002.

Data from the these inspections are not a representative sample of all

manufacturers using the most common food allergens, and the results should not

be generalized to all food production facilities, according to the FDA. The

facilities were selected based on certain criteria and not in an entirely random

fashion. Nevertheless, the results of these inspections provide insight into

current efforts to address the risks of food allergen cross contamination. Taken

together, the findings in the report suggest that a certain percentage of

facilities do attempt to address potential concerns associated with the use of

allegens in food products, but the extent to which a company does so varies.

Some companies did not apply any control measures in the handling and use of

allergens.


Celiac.com Sponsor (A8):
Celiac.com Sponsor (A8):



Celiac.com Sponsor (A8-M):



happygirl Collaborator

Jen,

Thanks for posting that!

Laura

jenvan Collaborator
Great post.

Though, now it just makes me even more paranoid about CC issues.

Perhaps with the added awareness, something will be done to address the very real issue of CC.

It does bring out the paranoia. I just think of stories of people dropping things, like body parts for example, in big vats of food and not reporting it :o

TriticusToxicum Explorer
I just think of stories of people dropping things, like body parts for example, in big vats of food and not reporting it :o

Now THAT'S something the FDA ought to be looking into!

Archived

This topic is now archived and is closed to further replies.

  • Get Celiac.com Updates:
    Support Celiac.com:
    Join eNewsletter
    Donate

  • Celiac.com Sponsor (A17):
    Celiac.com Sponsor (A17):





    Celiac.com Sponsors (A17-M):




  • Recent Activity

    1. - knitty kitty commented on knitty kitty's blog entry in Thiamine Thiamine Thiamine
      1

      Gastrointestinal Beriberi

    2. - drjay replied to drjay's topic in Celiac Disease Pre-Diagnosis, Testing & Symptoms
      3

      Unsteady in my new diagnosis

  • Celiac.com Sponsor (A19):
  • Member Statistics

    • Total Members
      133,898
    • Most Online (within 30 mins)
      10,442

    Ellen H
    Newest Member
    Ellen H
    Joined
  • Celiac.com Sponsor (A20):
  • Celiac.com Sponsor (A22):
  • Forum Statistics

    • Total Topics
      121.6k
    • Total Posts
      1m
  • Celiac.com Sponsor (A21):
  • Upcoming Events

  • Posts

    • drjay
      Thanks, yall! The tough part now is figuring out if I’m actually feeling better or is it some form of placebo effect. I do actually feel better but I’m not positive if I may just be gaslighting myself lol
    • Aretaeus Cappadocia
      @drjay in addition to what @trents wrote, I wanted to comment on your statement, "Positive for DQ2 and homozygous for DQB1*02 but negative for DQ8" You don't need DQ2 >and< DQ8 in order to be susceptible to getting celiac. Either one is good enough. DQB1*02 is a specific genetic allele that encodes part of the DQ2 protein. "Homozygous" means two copies of the same allele (the opposite is "heterozygous", where the two copies are different alleles). If you are homozygous for DQB1*02, you couldn't have DQ8. In other words, your genetic test tells you that you definitely have the potential to get celiac.   
    • trents
      @drjay, your mixed test results experience is exceedingly common for someone having been consuming reduced amounts of gluten. A Marsh scale score of 3 indicates "significant villous atrophy" according to a quick google search I did and the biopsy is the gold standard diagnostic test anyway, not the blood antibody testing. It doesn't look like a "total IGA" blood test was ordered and without that we cannot tell if you are IGA deficient. If IGA deficient, other celiac IGA antibody scores, such as the tTG-IGA, cannot be trusted. They will likely be artificially low. And given the fact that there is significant improvement in your symptoms once you went on a strict gluten free diet, there is no doubt in my mind that your doctor's diagnosis of celiac disease is the correct one. By the way, welcome to celiac.com.!
    • drjay
      About 2 years ago I got a referral to a GI because I was experiencing gut pain, bloating, and some other not so fun symptoms. He scheduled a colonoscopy and that came back fine with the exception of very small healing ulcers in my TI. I have a family history of stomach ulcers so I was prescribed a round of antibiotics and then placed on a PPI w/o an endoscopy to confirm. I think I may have convinced myself it was helping for about a year but I likely just acclimated to how I was feeling. Fast forward to January and my symptoms had gotten to be persistently unbearable and nothing was helping except some minor pressure relief from gasx. I get another appt with the GI and get an endoscopy done. There’s no ulcer so I stop the PPI and we do a SIBO test which comes back negative. The Dr orders a Labcorp celiac test immediately after he gets the biopsy results w/o the gluten challenge thing. I already don’t consume much if any because I suspected I may be sensitive to  gluten.  They grade the biopsy Marsh class 3 but my lab tests are weird and listed below IgA 11 (weak positive is 19) IgG 5 (weak positive is 19) tTG IgA 3 (weak positive 4) Positive for DQ2 and homozygous for DQB1*02 but negative for DQ8 My GI did diagnose as Celiac but the blood test makes me unsure. Even though I’ve been unsure, I immediately went on a strict gluten free diet. Yesterday makes 12 days and it was the first day with a normal bowel movement in last several weeks. Anyone have similar experience? 
    • knitty kitty
      I found these articles interesting. Among people already diagnosed with Celiac Disease, the HLA DQ B1*02 allele is present in about 95%...... Carrier frequency of HLA-DQB1*02 allele in patients affected with celiac disease: A systematic review assessing the potential rationale of a targeted allelic genotyping as a first-line screening https://pubmed.ncbi.nlm.nih.gov/32256023/   Total IgA levels can be affected by the same HLA DQ B1*02 allele..... Total serum IgA levels and HLA-DQB1*02:01 allelic status https://pubmed.ncbi.nlm.nih.gov/37725324/
×
×
  • Create New...

Important Information

NOTICE: This site places This site places cookies on your device (Cookie settings). on your device. Continued use is acceptance of our Terms of Use, and Privacy Policy.